Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 155 (2009), 1451-1458; DOI  10.1099/mic.0.025213-0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary figure
Right arrow All Versions of this Article:
mic.0.025213-0v1
155/5/1451    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bray, B. A.
Right arrow Articles by Harrington, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bray, B. A.
Right arrow Articles by Harrington, D. J.
Agricola
Right arrow Articles by Bray, B. A.
Right arrow Articles by Harrington, D. J.
Microbiology 155 (2009), 1451-1458; DOI  10.1099/mic.0.025213-0
© 2009 Society for General Microbiology

Impact of lgt mutation on lipoprotein biosynthesis and in vitro phenotypes of Streptococcus agalactiae

Beverley A. Bray1, Iain C. Sutcliffe2 and Dean J. Harrington1

1 University of Bradford, West Yorkshire BD7 1DP, UK
2 Northumbria University, Newcastle upon Tyne NE1 8ST, UK

Although Streptococcus agalactiae, the group B Streptococcus, is a leading cause of invasive neonatal disease worldwide the molecular basis of its virulence is still poorly understood. To investigate the role of lipoproteins in the physiology and interaction of this pathogen with host cells, we generated a mutant S. agalactiae strain (A909{Delta}Lgt) deficient in the Lgt enzyme and thus unable to lipidate lipoprotein precursors (pro-lipoproteins). The loss of pro-lipoprotein lipidation did not affect the viability of S. agalactiae or its growth in several different media, including cation-depleted media. The processing of two well-characterized lipoproteins, but not a non-lipoprotein, was clearly shown to be aberrant in A909{Delta}Lgt. The mutant strain was shown to be more sensitive to oxidative stress in vitro although the molecular basis of this increased sensitivity was not apparent. The inactivation of Lgt also resulted in changes to the bacterial cell envelope, as demonstrated by reduced retention of both the group B carbohydrate and the polysaccharide capsule and a statistically significant reduction (P=0.0079) in A909{Delta}Lgt adherence to human endothelial cells of fetal origin. These data confirm that failure to process lipoproteins correctly has pleiotropic effects that may be of significance to S. agalactiae colonization and pathogenesis.

Correspondence
Dean J. Harrington
d.harrington{at}bradford.ac.uk


Abbreviations: GBS, group B Streptococcus; HUVEC-C, human umbilical vein endothelial cell line; Lgt, prolipoprotein diacylglyceryl transferase; Lpp, lipoproteins

A supplementary figure showing the strategy for generating allelic replacement mutants of S. agalactiae A909 is available with the online version of this paper.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2009 Society for General Microbiology.